Index Entries - Covid Index

2025 Results

Title	IS Publication Date
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review	September 20, 2016
Reports of acute adverse events in mRNA COVID‑19 vaccine recipients after the first and second doses in Japan	September 15, 2022
Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of Death	February 4, 2025
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden	August 19, 2024
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States	February 1, 2023
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities	March 30, 2021
Research Letter re. 'Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis'	March 29, 2023
Research Letter: Acute Allergic Reactions to mRNA COVID-19 Vaccines	March 8, 2021
Research Letter: All-Cause Excess Mortality and COVID-19 - Related Mortality Among US Adults Aged 25-44 Years, March-July 2020	December 16, 2020
Research Letter: Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy	May 28, 2021
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk	September 26, 2022
Research Letter: Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant	May 18, 2022
Researchers studying reported menstrual changes after COVID-19 vaccination	July 8, 2021
Reset the Table: Meeting the Moment to Transform the U.S. Food System	July 28, 2020
Resignation in protest, Frontiers in Pharmacology - Topic Editors, “Treating COVID-19 With Currently Available Drugs”	April 23, 2021
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically	March 26, 2020
Response to Critics of Lee & Broudy (2024) on the Toxicity and Self-Assembling Technology in Incubated Samples of Injecta	September 17, 2024
Response to Request for Information (RFI): COVID-19 Misinformation from Official Sources During the Pandemic	May 2, 2022
Response: Ed Humpherson to Norman Fenton, Martin Neil, Clare Craig and Scott McLachlan: ONS Deaths by Vaccination Status statistics	January 23, 2023
Results of a systematic review and meta‑analysis of early studies on ivermectin in SARS‑CoV‑2 infection	March 7, 2023
Results of an Open Prospective Controlled Comparative Study on the Treatment of Novel Coronavirus Infection (COVID-19): Bromhexine & Spironolactone for the Treatment of Coronavirus Infection Requiring Hospitalization	May 11, 2020
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	February 23, 2021
Retracted Covid-19 articles: significantly more cited than other articles within their journal of origin	April 12, 2023
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2	December 30, 2021
Return to Wuhan: What Life Is Like One Year Later	January 24, 2021
Revealed: PR firm that represents Pfizer and Moderna also sits on CDC vaccine division - sparking major conflict of interest concerns	October 12, 2022
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues	May 25, 2021
Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome following vaccination: analysis of the VAERS database and systematic review	October 18, 2023
Review of COVID-19 Vaccines and the Risk of Chronic Adverse Events Including Neurological Degeneration	March 24, 2021
Review of scientific reports of harms caused by face masks, up to February 2021	February 22, 2021
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19	April 22, 2021
Review: Calls for Market Removal of COVID-19 Vaccines Intensify: Risks Far Outweigh Theoretical Benefits	January 28, 2025
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?	April 5, 2024
Revisiting Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements—United States, July 1—October 20 2021	May 25, 2022
Rhabdomyolysis Secondary to COVID-19 Vaccination	May 13, 2021
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	May 2, 2023
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	May 2, 2023
Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022	October 8, 2024
Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria	November 8, 2023
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study	September 2, 2024
Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS -CoV-2 infection in Germany	November 30, 2021
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden	February 4, 2022
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex	August 22, 2022
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England	June 7, 2023
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	August 19, 2022
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis	June 20, 2023
Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods	April 11, 2022
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia	November 21, 2023
Risk of severe COVID-19 infection among adults with prior exposure to children	July 27, 2022

Page 30 of 41